Global Beta-Lactam Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4858372
- 85 Pages
- February 2022
- Pharmaceuticals
The United States Beta-Lactam Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Beta-Lactam Drugs market, reaching US$ million by the year 2028. As for the Europe Beta-Lactam Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Beta-Lactam Drugs players cover GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca plc, and Merck & Co., Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Lactam Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Penicillin
Cephalosporins
Carbapenem
Monobacteria
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline plc
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Shionogi & Co., Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Beta-Lactam Drugs Market Size 2017-2028
2.1.2 Beta-Lactam Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Beta-Lactam Drugs Segment by Type
2.2.1 Penicillin
2.2.2 Cephalosporins
2.2.3 Carbapenem
2.2.4 Monobacteria
2.3 Beta-Lactam Drugs Market Size by Type
2.3.1 Beta-Lactam Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Beta-Lactam Drugs Market Size Market Share by Type (2017-2022)
2.4 Beta-Lactam Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Beta-Lactam Drugs Market Size by Application
2.5.1 Beta-Lactam Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Beta-Lactam Drugs Market Size Market Share by Application (2017-2022)
3 Beta-Lactam Drugs Market Size by Player
3.1 Beta-Lactam Drugs Market Size Market Share by Players
3.1.1 Global Beta-Lactam Drugs Revenue by Players (2020-2022)
3.1.2 Global Beta-Lactam Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Beta-Lactam Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Beta-Lactam Drugs by Regions
4.1 Beta-Lactam Drugs Market Size by Regions (2017-2022)
4.2 Americas Beta-Lactam Drugs Market Size Growth (2017-2022)
4.3 APAC Beta-Lactam Drugs Market Size Growth (2017-2022)
4.4 Europe Beta-Lactam Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Beta-Lactam Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Beta-Lactam Drugs Market Size by Country (2017-2022)
5.2 Americas Beta-Lactam Drugs Market Size by Type (2017-2022)
5.3 Americas Beta-Lactam Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Lactam Drugs Market Size by Region (2017-2022)
6.2 APAC Beta-Lactam Drugs Market Size by Type (2017-2022)
6.3 APAC Beta-Lactam Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Beta-Lactam Drugs by Country (2017-2022)
7.2 Europe Beta-Lactam Drugs Market Size by Type (2017-2022)
7.3 Europe Beta-Lactam Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Beta-Lactam Drugs by Region (2017-2022)
8.2 Middle East & Africa Beta-Lactam Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Beta-Lactam Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Beta-Lactam Drugs Market Forecast
10.1 Global Beta-Lactam Drugs Forecast by Regions (2023-2028)
10.1.1 Global Beta-Lactam Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Beta-Lactam Drugs Forecast
10.1.3 APAC Beta-Lactam Drugs Forecast
10.1.4 Europe Beta-Lactam Drugs Forecast
10.1.5 Middle East & Africa Beta-Lactam Drugs Forecast
10.2 Americas Beta-Lactam Drugs Forecast by Country (2023-2028)
10.2.1 United States Beta-Lactam Drugs Market Forecast
10.2.2 Canada Beta-Lactam Drugs Market Forecast
10.2.3 Mexico Beta-Lactam Drugs Market Forecast
10.2.4 Brazil Beta-Lactam Drugs Market Forecast
10.3 APAC Beta-Lactam Drugs Forecast by Region (2023-2028)
10.3.1 China Beta-Lactam Drugs Market Forecast
10.3.2 Japan Beta-Lactam Drugs Market Forecast
10.3.3 Korea Beta-Lactam Drugs Market Forecast
10.3.4 Southeast Asia Beta-Lactam Drugs Market Forecast
10.3.5 India Beta-Lactam Drugs Market Forecast
10.3.6 Australia Beta-Lactam Drugs Market Forecast
10.4 Europe Beta-Lactam Drugs Forecast by Country (2023-2028)
10.4.1 Germany Beta-Lactam Drugs Market Forecast
10.4.2 France Beta-Lactam Drugs Market Forecast
10.4.3 UK Beta-Lactam Drugs Market Forecast
10.4.4 Italy Beta-Lactam Drugs Market Forecast
10.4.5 Russia Beta-Lactam Drugs Market Forecast
10.5 Middle East & Africa Beta-Lactam Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Beta-Lactam Drugs Market Forecast
10.5.2 South Africa Beta-Lactam Drugs Market Forecast
10.5.3 Israel Beta-Lactam Drugs Market Forecast
10.5.4 Turkey Beta-Lactam Drugs Market Forecast
10.5.5 GCC Countries Beta-Lactam Drugs Market Forecast
10.6 Global Beta-Lactam Drugs Forecast by Type (2023-2028)
10.7 Global Beta-Lactam Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Information
11.1.2 GlaxoSmithKline plc Beta-Lactam Drugs Product Offered
11.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline plc Main Business Overview
11.1.5 GlaxoSmithKline plc Latest Developments
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Information
11.2.2 Pfizer, Inc. Beta-Lactam Drugs Product Offered
11.2.3 Pfizer, Inc. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer, Inc. Main Business Overview
11.2.5 Pfizer, Inc. Latest Developments
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Information
11.3.2 AstraZeneca plc Beta-Lactam Drugs Product Offered
11.3.3 AstraZeneca plc Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AstraZeneca plc Main Business Overview
11.3.5 AstraZeneca plc Latest Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Information
11.4.2 Merck & Co., Inc. Beta-Lactam Drugs Product Offered
11.4.3 Merck & Co., Inc. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck & Co., Inc. Main Business Overview
11.4.5 Merck & Co., Inc. Latest Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Information
11.5.2 Eli Lilly and Company Beta-Lactam Drugs Product Offered
11.5.3 Eli Lilly and Company Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly and Company Main Business Overview
11.5.5 Eli Lilly and Company Latest Developments
11.6 Shionogi & Co., Ltd.
11.6.1 Shionogi & Co., Ltd. Company Information
11.6.2 Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offered
11.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Shionogi & Co., Ltd. Main Business Overview
11.6.5 Shionogi & Co., Ltd. Latest Developments
12 Research Findings and Conclusion
Table 1. Beta-Lactam Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Penicillin
Table 3. Major Players of Cephalosporins
Table 4. Major Players of Carbapenem
Table 5. Major Players of Monobacteria
Table 6. Beta-Lactam Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Beta-Lactam Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Beta-Lactam Drugs Market Size Market Share by Type (2017-2022)
Table 9. Beta-Lactam Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Beta-Lactam Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Beta-Lactam Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global Beta-Lactam Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Beta-Lactam Drugs Revenue Market Share by Player (2020-2022)
Table 14. Beta-Lactam Drugs Key Players Head office and Products Offered
Table 15. Beta-Lactam Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Beta-Lactam Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Beta-Lactam Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas Beta-Lactam Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Beta-Lactam Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas Beta-Lactam Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Beta-Lactam Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas Beta-Lactam Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Beta-Lactam Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC Beta-Lactam Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Beta-Lactam Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC Beta-Lactam Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Beta-Lactam Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC Beta-Lactam Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Beta-Lactam Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe Beta-Lactam Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Beta-Lactam Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe Beta-Lactam Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Beta-Lactam Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe Beta-Lactam Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Beta-Lactam Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Beta-Lactam Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Beta-Lactam Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Beta-Lactam Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Beta-Lactam Drugs
Table 45. Key Market Challenges & Risks of Beta-Lactam Drugs
Table 46. Key Industry Trends of Beta-Lactam Drugs
Table 47. Global Beta-Lactam Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Beta-Lactam Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Beta-Lactam Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Beta-Lactam Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Beta-Lactam Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Beta-Lactam Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. GlaxoSmithKline plc Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 54. GlaxoSmithKline plc Beta-Lactam Drugs Product Offered
Table 55. GlaxoSmithKline plc Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. GlaxoSmithKline plc Main Business
Table 57. GlaxoSmithKline plc Latest Developments
Table 58. Pfizer, Inc. Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 59. Pfizer, Inc. Beta-Lactam Drugs Product Offered
Table 60. Pfizer, Inc. Main Business
Table 61. Pfizer, Inc. Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Pfizer, Inc. Latest Developments
Table 63. AstraZeneca plc Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 64. AstraZeneca plc Beta-Lactam Drugs Product Offered
Table 65. AstraZeneca plc Main Business
Table 66. AstraZeneca plc Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. AstraZeneca plc Latest Developments
Table 68. Merck & Co., Inc. Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 69. Merck & Co., Inc. Beta-Lactam Drugs Product Offered
Table 70. Merck & Co., Inc. Main Business
Table 71. Merck & Co., Inc. Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Merck & Co., Inc. Latest Developments
Table 73. Eli Lilly and Company Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 74. Eli Lilly and Company Beta-Lactam Drugs Product Offered
Table 75. Eli Lilly and Company Main Business
Table 76. Eli Lilly and Company Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Eli Lilly and Company Latest Developments
Table 78. Shionogi & Co., Ltd. Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 79. Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offered
Table 80. Shionogi & Co., Ltd. Main Business
Table 81. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Shionogi & Co., Ltd. Latest Developments
List of Figures
Figure 1. Beta-Lactam Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Beta-Lactam Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Beta-Lactam Drugs Market Size Market Share by Type in 2021
Figure 7. Beta-Lactam Drugs in Hospital Pharmacies
Figure 8. Global Beta-Lactam Drugs Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Beta-Lactam Drugs in Retail Pharmacies
Figure 10. Global Beta-Lactam Drugs Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Beta-Lactam Drugs in Online Pharmacies
Figure 12. Global Beta-Lactam Drugs Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Beta-Lactam Drugs Market Size Market Share by Application in 2021
Figure 14. Global Beta-Lactam Drugs Revenue Market Share by Player in 2021
Figure 15. Global Beta-Lactam Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Beta-Lactam Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Beta-Lactam Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Beta-Lactam Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Beta-Lactam Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Beta-Lactam Drugs Value Market Share by Country in 2021
Figure 21. Americas Beta-Lactam Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Beta-Lactam Drugs Market Size Market Share by Application in 2021
Figure 23. United States Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Beta-Lactam Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Beta-Lactam Drugs Market Size Market Share by Application in 2021
Figure 29. China Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Beta-Lactam Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Beta-Lactam Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Beta-Lactam Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Beta-Lactam Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Beta-Lactam Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
